Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy ADMA Biologics stock (ADMA)

Buy ADMA Biologics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

ADMA Biologics is a biotechnology business based in the US. ADMA Biologics shares (ADMA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19.32 – a decrease of 3.95% over the previous week. ADMA Biologics employs 624 staff and has a trailing 12-month revenue of around $382.8 million.

Our top picks for where to buy ADMA Biologics stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Complimentary access to a financial planner

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

How to buy ADMA Biologics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ADMA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy ADMA Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Crypto alternative
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ADMA Biologics stock price (NASDAQ: ADMA)

Use our graph to track the performance of ADMA stocks over time.

ADMA Biologics shares at a glance

Information last updated 2024-12-04.
Latest market close$19.32
52-week range$3.60 - $23.64
50-day moving average $19.03
200-day moving average $12.72
Wall St. target price$23.45
PE ratio 73.8889
Dividend yield N/A
Earnings per share (TTM) $0.27

Is it a good time to buy ADMA Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ADMA Biologics price performance over time

Historical closes compared with the close of $19.315 from 2024-12-05

1 week (2024-11-29) -3.95%
1 month (2024-11-07) -2.05%
3 months (2024-09-06) 18.79%
6 months (2024-06-07) 84.48%
1 year (2023-12-07) 412.33%
2 years (2022-12-07) 459.86%
3 years (2021-12-07) 1,320.22%
5 years (2019-12-06) 347.11%

Is ADMA Biologics stock undervalued or overvalued?

Valuing ADMA Biologics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ADMA Biologics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ADMA Biologics's P/E ratio

ADMA Biologics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, ADMA Biologics shares trade at around 74x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ADMA Biologics's EBITDA

ADMA Biologics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $125.9 million.

The EBITDA is a measure of a ADMA Biologics's overall financial performance and is widely used to measure a its profitability.

ADMA Biologics financials

Revenue TTM $382.8 million
Operating margin TTM 33.08%
Gross profit TTM $35.3 million
Return on assets TTM 19.89%
Return on equity TTM 35.55%
Profit margin 17.8%
Book value $0.98
Market Capitalization $4.7 billion

TTM: trailing 12 months

ADMA Biologics share dividends

We're not expecting ADMA Biologics to pay a dividend over the next 12 months.

ADMA Biologics share price volatility

Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $3.6 up to $23.64. A popular way to gauge a stock's volatility is its "beta".

ADMA.US volatility(beta: 0.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 0.645. This would suggest that ADMA Biologics's shares are less volatile than average (for this exchange).

ADMA Biologics overview

ADMA Biologics, Inc. , a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers.

Frequently asked questions

null
What percentage of ADMA Biologics is owned by insiders or institutions?
Currently 2.51% of ADMA Biologics shares are held by insiders and 90.888% by institutions.
How many people work for ADMA Biologics?
Latest data suggests 624 work at ADMA Biologics.
When does the fiscal year end for ADMA Biologics?
ADMA Biologics's fiscal year ends in December.
Where is ADMA Biologics based?
ADMA Biologics's address is: 465 State Route 17, Ramsey, NJ, United States, 07446
What is ADMA Biologics's ISIN number?
ADMA Biologics's international securities identification number is: US0008991046
What is ADMA Biologics's CUSIP number?
ADMA Biologics's Committee on Uniform Securities Identification Procedures number is: 000899104

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site